[1] SCHON H T,BARTNECK M,BORKHAM-KAMPHORST E,et al. Pharmacological intervention in hepatic stellate cell activation and hepatic fibrosis[J]. Front Pharmacol,2016, 7:33.[2] 秦棪楠,钟耀刚,李铮. 人肝星状细胞激活和抑制及其相关分子机制的研究进展[J]. 中国细胞生物学报,2011, 33(10):1127-1136.[3] 徐向南,肖永胜,樊嘉. 肝星状细胞与肝癌的研究进展[J]. 中国临床医学,2012,19(6):705-707.[4] XIE W L,JIANG R,SHEN X L,et al. Diosgenin attenuates hepatic stellate cell activation through transforming growth factor-β/Smad signaling pathway[J]. Int J Clin Exp Med, 2015,8(11):20323-20329.[5] 李媛,宋媛媛,张洪泉. 肉苁蓉的化学成分及药理作用研究进展[J]. 中国野生植物资源,2010,29(1):7-12.[6] 宋鹏,屠鹏飞. 中药肉苁蓉质量控制及评价的研究进展[J]. 北方药学,2011,8(2):61-62.[7] 屠鹏飞,姜勇,郭玉海. 肉苁蓉研究及其产业发展[J]. 中国药学杂志,2011,46(12):882-888.[8] 陈海燕,郝彩琴,郭鸿雁. 肉苁蓉药用资源开发与应用研究进展[J]. 价值工程,2012,31(3):303-305.[9] SHU-PING YOU,JUN ZHAO,LONG M A,et al. Preventive effects of phenylethanol glycosides from Cistanche tubulosa on bovine serum albumin induced hepatic fibrosis in rats[J]. DARU J Pharm Sci,2015,23:135-139.[10] 由淑萍,赵军,木克热木·吐地买提,等. 肉苁蓉苯乙醇苷类成分对BSA诱导的肝纤维化大鼠转化生长因子β1表达的影响[J]. 癌变·畸变·突变,2015,27(6):409-414.[11] MARCELLIN P,GANE E,BUTI M,et al. Regression of cirrhosis during treatment with tenofovir disoproxil fumarate for chronic hepatitis B:a 5-year open-label follow-up study[J]. Lancet, 2013,381(9865):468-475.[12] PUCHE J E,SAIMAN Y,FRIEDMAN S L. Hepatic stellate cells and liver fibrosis[J]. Compr Physiol,2013,3:1473-1492.[13] GéLINAS S,MARTINOLI M G. Neuroprotective effect of estradiol and phytoestrogens on MPP+-induced cytotoxicity in neuronal PC12 cells[J]. J Neurosci Res,2002,70:90-96.[14] JIN H,LIAN N,ZHANG F,et al. Activation of PPAR γ/P53 signaling is required for curcumin to induce hepatic stellate cell senescence[J]. Cell Death Dis,2016,7:e2189.[15] WANG Y,WANG R,WANG Y,et al. Ginkgo biloba extract mitigates liver fibrosis and apoptosis by regulating p38 MAPK, NF-κB/IκBα,and Bcl-2/Bax signaling[J]. Drug Des Devel Ther,2015,9:6303-6317. |